Finally Some Good News as the FDA Lifts Hold on Sanofi, Alnylam's Fitusiran Post author:Sam Post published:December 14, 2017 Post category:BioPharma Clinical trial dosing will resume around year-end 2017. Source: BioSpace You Might Also Like Quotient Limited Release: Company To Report Third Quarter Fiscal 2017 Financial Results And Host Conference Call January 23, 2017 Recro Pharma Reports Inducement Grants For New Staff August 10, 2017 Mauna Kea Technologies: Cellvizio Now CE Marked For Use During Robotic-Assisted Surgery October 9, 2017
Quotient Limited Release: Company To Report Third Quarter Fiscal 2017 Financial Results And Host Conference Call January 23, 2017
Mauna Kea Technologies: Cellvizio Now CE Marked For Use During Robotic-Assisted Surgery October 9, 2017
